Miracle
Accelerate clinical trials with real-time, actionable insights
Founders
Not read from YC yet; the weekly run fills these in.
Same space
Competitors
Closest in what they build, same category.
Adjacent
Overlapping tags, a different niche.
GleamS23Automating Data Entry for Clinical TrialsShared: biotech, healthcareActive
NovelcareW23Empowering every doctor and every patient to participate in researchShared: healthcareActive
FrekilX25RWE Generation in minutesShared: biotech, healthcareActive
OsseusS26The frontier data platform for aligned health and biological AIShared: biotech, healthcareActive
Maven BioS23Live intelligence for biopharma teams.Shared: biotech, healthcareActive
Also from W23
Batchmates in Winter 2023.
CombineHealthW23Automating Healthcare Revenue Cycle Management with AI WorkforceActive
Diffuse BioW23Generative AI for protein designActive
Fairway HealthW23AI Co-Pilot for Health Insurers to Authorize Treatment FasterAcquired
Glass HealthW23AI-Powered Clinical Decision Support & Ambient ScribingActive
Hippo ScribeW23AI assisted documentation for PT/OT/SLPActive
Kivo HealthW23AI-powered care for seniors with chronic diseaseActive
About Miracle
Miracle is the control room for clinical trials. Our platform consolidates data from multiple trial systems into real-time dashboards, delivering automated insights that empower clinical-stage biopharmaceutical companies to streamline operations, reduce manual workflows, and accelerate data-driven decision-making. By transforming complex trial data into actionable insights, Miracle helps biopharma teams speed up clinical trials, and ultimately, improve patient outcomes.
San Francisco, CA, USA
Miracle: questions
Which YC batch was Miracle in?
Miracle was in Y Combinator's Winter 2023 batch (W23).
Is Miracle still active?
Y Combinator lists Miracle as active.
Where is Miracle based?
Miracle lists San Francisco, CA, USA as its location on YC's directory.
Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.